Daprodustat cas: 960539-70-2 HIF-PHs inhibitors; Erythropoiesis irritant Original research company: GlaxoSmithKline has been listed in 2022 Indications: Anemia; Allergic bronchopulmonary aspergillosis; Peripheral vascular diseases; Tendon injury; kidney disease